Pedvaxhib 00006-4897
Generic: Haemophilus B Conjugate Vaccine (meningococcal Protein Conjugate)
Product NDC
00006-4897- Manufacturer
- Merck Sharp & Dohme Llc
- Dosage Form
- Injection, Suspension
- Route
- Intramuscular
- Product Type
- Vaccine
- Marketing Start
- December 20, 1989
- Listing Expires
- December 31, 2026
- Application
- BLA103237
Active Ingredients
| Ingredient | Strength |
|---|---|
| Haemophilus Influenzae Type B Capsular Polysaccharide Meningococcal Outer Membrane Protein Conjugate Antigen | 7.5 ug/.5mL |
Drug Class
Actively Acquired Immunity [PE]Haemophilus Vaccines [CS]Inactivated Haemophilus Influenzae B Vaccine [EPC]
Packaging Options(1)
10 VIAL, SINGLE-DOSE in 1 CARTON (0006-4897-00) / .5 mL in 1 VIAL, SINGLE-DOSE (0006-4897-01)
External Resources